Skip to main content

Zusammenfassung

Die im englischen Sprachraum gebräuchliche Bezeichnung „cancer related fatigue“ (CRF) ist weitaus zutreffender als die früher im deutschen Sprachraum genutzten Begriffe „Müdigkeit“ und „Erschöpfung“. Definitionsgemäß ist das allgemeine Fatigue-Syndrom von dem Krebs- bzw. dem Krebstherapie-assoziierten Fatigue-Syndrom abzugrenzen, wenngleich Parallelen zu physischer und mentaler Erschöpfungsausprägung zu erkennen sind. Die folgenden Ausführungen beziehen sich auf die krebsinduzierte Erschöpfung und werden daher mit der Abkürzung CRF benannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Agteresch HJ, Dagnelie PC, van der Gaast A, Stijnen T, Wilson JH (2000) Randomized clinical trial of adenosine 5′-triphosphate in patients with advanced non-small-cell lung cancer. Journal of the National Cancer Institute 92(4):321–8

    Google Scholar 

  • Aguilera G (1994) Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15:321–350

    Google Scholar 

  • Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M; GENEQOL Consortium (2010) I’m so tired: biological and genetic mechanisms of cancer-related fatigue. Qual Life Res 19(10):1419–1427

    Google Scholar 

  • Blackshaw LA, Grundy D (1993a) Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 45:41–50

    Google Scholar 

  • Blackshaw LA, Grundy D (1993b) Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 45:51–59

    Google Scholar 

  • Bower JE (2008) Behavioral symptoms in patients with breast cancer and survivors. J Clin Oncol 26(5):768–777

    Google Scholar 

  • Bower JE, Ganz PA, Aziz N, Fahey JL (2002) Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine 64(4):604–11

    Google Scholar 

  • Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW, Bower JE, Ganz PA, Aziz N et al. (2003) T-cell homeostasis in breast cancer survivors with persistent fatigue. Journal of the National CancerInstitute 95(15):1165–1168

    Google Scholar 

  • Bower JE, Ganz PA, Desmond KA (2000) Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743–753

    Google Scholar 

  • Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, Klimas NG, Marshall-Gradisnik SM (2011) Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med 9:81

    Google Scholar 

  • Bruera E, Driver L, Barnes EA, Willey J, Shen L, Palmer JL et al. (2003) Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 21(23):4439–4443

    Google Scholar 

  • Cella D, Davis K, Breitbart W et al. (2001) Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 19:3385–3391

    Google Scholar 

  • Chappell PB, Smith MA, Kilts CD et al. (1986) Alterations in corticotropinreleasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908–2914

    Google Scholar 

  • Chen R, Liang FX, Moriya J, Yamakawa J, Sumino H, Kanda T, Takahashi T (2008) Chronic fatigue syndrome and the central nervous system. J Int Med Res 36(5):867–874, Review

    Google Scholar 

  • Cleare AJ (2003) The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 24:236–252

    Google Scholar 

  • Cleare AJ, Miell J, Heap E et al. (2001) Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 86:3545–3554

    Google Scholar 

  • Collado-Hidalgo A, Bower JE, Ganz PA, Irwin MR, Cole SW (2008) Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain, Behavior, and Immunity 22:1197–1200

    Google Scholar 

  • Cramp F, Daniel J (2008) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 16(2):CD006145

    Google Scholar 

  • D’Andrea MD (2005) Use of Antioxidants During Chemotherapy and Radiotherapy Should Be Avoided. Cancer Journal for Clinicians 55:319–321

    Google Scholar 

  • Duval F, Mokrani MC, Monreal-Ortiz JA et al. (2006) Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features: Dopaminergic, noradrenergic and thyroid correlates. Psychoneuroendocrinology 31:876–888

    Google Scholar 

  • Ek M, Kurosawa M, Lundeberg T et al. (1998) Activation of vagal afferents after intravenous injection of interleukin-1β: Role of endogenous prostaglandins. J Neurosci 18:9471–9479

    Google Scholar 

  • Febbraio MA, Steensberg A, Keller C, Starkie RL, Nielsen HB, Krustrup P et al. (2003) Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. Journal of Physiology 549(2):607–612

    Google Scholar 

  • Fernstrom JD, Fernstrom MH (2006) Exercise, serum free tryptophan, and central fatigue. J Nutr 136, Suppl):553S–559S

    Google Scholar 

  • Forsyth LM, Preuss HG, MacDowell AL et al. (1999) Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 82:185–191

    Google Scholar 

  • Gilliam LA, St Clair DK (2011) Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress. Antioxid Redox Signal 15: 2543–2563

    Google Scholar 

  • Grote HE, Hannan AJ (2007) Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol 34(5–6):533–545

    Google Scholar 

  • Higginson IJ, Armes J, Krishnasamy M (2004) Introduction, in fatigue in cancer. In: Armes J, Krishnasamy M, Higginson IJ (eds) Fatigue in Cancer. Oxford University Press, Oxford; xvii–xxi

    Google Scholar 

  • Imaki T, Nahan J-L, Rivier C et al. (1991) Differential regulation of corticotrophin- releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 11:585–599

    Google Scholar 

  • Konsman JP, Parnet P, Dantzer R (2002) Cytokine-induced sickness behaviour: Mechanisms and implications. Trends Neurosci 25:154–159

    Google Scholar 

  • Kurzrock R (2001) The role of cytokines in cancer-related fatigue. Cancer 92(6 Suppl):1684–1688

    Google Scholar 

  • Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S (2008) Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 26(34):5618–5629 [Epub 2008 Nov 3rd. Review]

    Google Scholar 

  • Luebbert K, Dahme B, Hasenbring M (2001) The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology 10(6):490–502

    Google Scholar 

  • Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2011) Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med Sci Monit 17(4):SC11–15

    Google Scholar 

  • Maes M, Lin A, Bonaccorso S et al. (1998) Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 98:328–335

    Google Scholar 

  • McCully KK, Natelson BH, Iotti S et al. (1996) Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle Nerve 19:621–625

    Google Scholar 

  • McNeely ML, Courneya KS (2010) Exercise programs for cancer-related fatigue: evidence and clinical guidelines. J Natl Compr Canc Netw 8(8):945–953

    Google Scholar 

  • McNeely ML, Peddle CJ, Parliament M, Courneya KS (2006) Cancer rehabilitation: recommendations for integrating exercise programming in the clinical practice setting. Curr Cancer Therapy Rev 2:351–360

    Google Scholar 

  • Meyers CA, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4):788–793

    Google Scholar 

  • Morrow GR, Andrews PLR, Hickok JT et al. (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10:389–398

    Google Scholar 

  • Morrow GR, Hickok JT, Roscoe JA et al. (2003) Differential effects of paroxetine on fatigue and depression: A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21:4635–4641

    Google Scholar 

  • Nakajima K, Takeoka M, Mori M, Hashimoto S, Sakurai A, Nose H, Higuchi K, Itano N, Shiohara M, Oh T, Taniguchi S (2010) Exercise effects on methylation of ASC gene. Int J Sports Med 31(9):671–675

    Google Scholar 

  • Newsholme EA (1986) Application of principles of metabolic control to the problem of metabolic limitations in sprinting, middle-distance, and marathon running. Int J Sports Med 7, Suppl 1:66–70

    Google Scholar 

  • Newsholme EA, Blomstrand E (1995) Tryptophan, 5-hydroxytryptamine and a possible explanation for central fatigue. Adv Exp Med Biol 384:315–320

    Google Scholar 

  • Pastoris O, Aquilani R, Foppa P et al. (1997) Altered muscle energy metabolism in post-absorptive patients with chronic renal failure. Scand J Urol Nephrol 31:281–287

    Google Scholar 

  • Pedersen BK (2006) The anti-inflammatory effect of exercise: Its role in diabetes and cardiovascular diseasecontrol. Essays in Biochemistry 42:105–117

    Google Scholar 

  • Pedersen BK, Fischer CP (2007) Physiological roles of muscle-derived interleukin-6 in response to exercise. Current Opinion in Clinical Nutrition and Metabolic Care 10(3):265–271

    Google Scholar 

  • Rich TA (2007) Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. The Journal of Supportive Oncology 5(4):167–174

    Google Scholar 

  • Roscoe JA, Morrow GR, Hickok JT et al. (2005) Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 89:243–249

    Google Scholar 

  • Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR (2007) Mechanisms of cancerrelated fatigue. The Oncologist 12, Suppl 1:22–34

    Google Scholar 

  • Schütz F (2008) Fatigue – ein unterschätztes Symptom bei Krebs. Gynäkologe 41:603–606

    Google Scholar 

  • Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8(11):887–899

    Google Scholar 

  • Seyidova-Khoshknabi D, Davis MP, Walsh D (2011) Review article: a systematic review of cancer-related fatigue measurement questionnaires. Am J Hosp Palliat Care 28(2):119–119 [Epub 2010 Nov 4th]

    Google Scholar 

  • Simone CB 2nd, Simone NL, Simone V, Simone CB (2007) Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13(1):22–28. Review.

    Google Scholar 

  • Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4(2):87–100 [Epub 2010 Jan 6]

    Google Scholar 

  • van Waart H, Stuiver MM, van Harten WH, Sonke GS, Aaronson NK (2010) Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue. BMC Cancer 10:673

    Google Scholar 

  • Velthuis MJ, May AM, Koppejan-Rensenbrink RA, Gijsen BC, van Breda E, de Wit GA, Schröder CD, Monninkhof EM, Lindeman E, van der Wall E, Peeters PH (2010) Physical Activity during Cancer Treatment (PACT) Study: design of a randomised clinical trial. BMC Cancer 10:272

    Google Scholar 

  • Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS, Shephard RJ, Oliver SJ, Bermon S, Kajeniene A. Position statement (2011a) Part two: Maintaining immune health. Exerc Immunol Rev 17:64–103. Review

    Google Scholar 

  • Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P (2011b) Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 17:6–63. Review

    Google Scholar 

  • Wichers M, Maes M (2002) The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol 5:375–388

    Google Scholar 

  • Wood LJ, Nail LM, Winters KA (2009) Does muscle-derived interleukin-6 mediate some of the beneficial effects of exercise on cancer treatment-related fatigue? Oncol Nurs Forum 36(5):519–524

    Google Scholar 

  • Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121–2131

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zimmer, P., Rüffer, J. (2012). Fatigue-Syndrom. In: Sport und körperliche Aktivität in der Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25066-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-25066-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-25065-1

  • Online ISBN: 978-3-642-25066-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics